Related references
Note: Only part of the references are listed.Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatment
Xiaojie Chen et al.
ACTA PHARMACEUTICA SINICA B (2021)
Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis
Mona Kamal Saadeldin et al.
MEDICAL HYPOTHESES (2021)
Inhibition of furin by bone targeting superparamagnetic iron oxide nanoparticles alleviated breast cancer bone metastasis
Yichuan Pang et al.
BIOACTIVE MATERIALS (2021)
CTLA4 blockade promotes vessel normalization in breast tumors via the accumulation of eosinophils
Xichen Zheng et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Saikosaponin D loaded macrophage membrane-biomimetic nanoparticles target angiogenic signaling for breast cancer therapy
Kaiju Sun et al.
APPLIED MATERIALS TODAY (2020)
Cancer immunotherapy: Pros, cons and beyond
Shuzhen Tan et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug
Mandy Juarez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy
Xinyu Hou et al.
ACTA PHARMACEUTICA SINICA B (2020)
Developing oncolytic viruses for clinical use: A consortium approach
Vera Kemp et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Engineering and combining oncolytic measles virus for cancer therapy
Mathias F. Leber et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
CRISPR screen in mechanism and target discovery for cancer immunotherapy
Dan Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Comprehensive Analysis of the Expression and Prognosis for TDO2 in Breast Cancer
Qiang Liu et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Withaferin A suppresses breast cancer cell proliferation by inhibition of the two-pore domain potassium (K2P9) channel TASK-3
Rafael Zuniga et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
被撤回的出版物: LncRNA GAS6-AS1 facilitates the progression of breast cancer by targeting the miR-324-3p/SETD1A axis to activate the PI3K/AKT pathway (Retracted article. See vol. 102, 2023)
Sijie Li et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2020)
Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
Luana Guerra et al.
CELL REPORTS (2020)
Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects
Joyobrato Nath et al.
LIFE SCIENCES (2020)
TRIM27 Functions as a Novel Oncogene in Non-Triple-Negative Breast Cancer by Blocking Cellular Senescence through p21 Ubiquitination
Li Xing et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
A highly potent PROTAC androgen receptor (AR) degrader ARD-61 effectively inhibits AR-positive breast cancer cell growth in vitro tumor growth in vivo
Lijie Zhao et al.
NEOPLASIA (2020)
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
Yuefei Zhu et al.
ACTA PHARMACEUTICA SINICA B (2020)
A look into the link between centrosome amplification and breast cancer
Yingzi Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Antibody and antibody fragments for cancer immunotherapy
Weizhi Chen et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer
Jeremy Beguin et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Reflectance structured illumination imaging of internalized cerium oxide nanoparticles modulating dose-dependent reactive oxygen species in breast cancer cells
Melissa Do et al.
BIOCHEMISTRY AND BIOPHYSICS REPORTS (2020)
A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study
Mowafak Masoud Bahaddin
ANNALS OF MEDICINE AND SURGERY (2020)
Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that Can Be Exploited by Targeting DNA Polymerase ε
Vladislav O. Sviderskiy et al.
MOLECULAR CELL (2020)
The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment
Yaxin Huang et al.
CANCERS (2020)
Advances in non and minimal-invasive transcutaneous delivery of immunotherapy for cancer treatment
Thuy Trang Nguyen et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Leptomeningeal metastatic hormone receptor positive, HER2 and PD-L1 negative, breast cancer responds after pembrolizumab added to abemaciclib: A case study
Melissa Mahoney et al.
CURRENT PROBLEMS IN CANCER: CASE REPORTS (2020)
Modern surgical treatment of breast cancer
M. Riis
ANNALS OF MEDICINE AND SURGERY (2020)
Mathematical Analysis of a Mathematical Model of Chemovirotherapy: Effect of Drug Infusion Method
Joseph Malinzi
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2019)
Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid
Qin Wang et al.
DRUG DELIVERY (2019)
Starch nanoparticles for delivery of the histone deacetylase inhibitor CG-1521 in breast cancer treatment
Esma Alp et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB)
Qing Ma et al.
BIOMED RESEARCH INTERNATIONAL (2019)
A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia
D. S. Rodrigues et al.
APPLIED MATHEMATICS AND COMPUTATION (2019)
Mathematical modeling in cancer nanomedicine: a review
Prashant Dogra et al.
BIOMEDICAL MICRODEVICES (2019)
Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to
Renee Brady et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2019)
Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo
Gang Zheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Recent advances in oncolytic virus-based cancer therapy
Luo-Qin Fu et al.
VIRUS RESEARCH (2019)
Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
Andrea Emanuele Guerini et al.
CANCERS (2019)
Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer
Wei Sun et al.
BIOMATERIALS (2019)
Recent advances in nanotheranostics for triple negative breast cancer treatment
Vikram Thakur et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Experimentally-driven mathematical modeling to improve combination targeted and cytotoxic therapy for HER2+breast cancer
Angela M. Jarrett et al.
SCIENTIFIC REPORTS (2019)
ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women
Alana A. Lewin et al.
Journal of the American College of Radiology (2019)
Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing
Jinyan Chan et al.
BIOINFORMATICS (2019)
Evaluation of a self-nanoemulsifying docetaxel delivery system
S. Akhtartavan et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Tramadol use is associated with enhanced postoperative outcomes in breast cancer patients: a retrospective clinical study with in vitro confirmation
Myoung H. Kim et al.
BRITISH JOURNAL OF ANAESTHESIA (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPRER and beyond
Safikur Rahman et al.
SAUDI PHARMACEUTICAL JOURNAL (2019)
Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
Meijun Zheng et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer
Jing Tang et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2019)
Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy
Maria E. Sales et al.
CURRENT CLINICAL PHARMACOLOGY (2019)
Use of amantadine as substrate for SSAT-1 activity as a reliable clinical diagnostic assay for breast and lung cancer
Andrew W. Maksymiuk et al.
FUTURE SCIENCE OA (2019)
Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer
Patricia Fernandez-Nogueira et al.
CANCER LETTERS (2018)
HER2-Targeted Multifunctional Silica Nanoparticles Specifically Enhance the Radiosensitivity of HER2-Overexpressing Breast Cancer Cells
Haruka Yamaguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Role of the nervous system in cancer metastasis
Nyanbol Kuol et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Associations Between Catecholaminergic and Serotonergic Genes and Persistent Breast Pain Phenotypes After Breast Cancer Surgery
Mitchell R. Knisely et al.
JOURNAL OF PAIN (2018)
Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
Nikolas Tim Martin et al.
MOLECULAR THERAPY (2018)
Combination therapy for cancer with oncolytic virus and checkpoint inhibitor: A mathematical model
Avner Friedman et al.
PLOS ONE (2018)
Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
Suman Bishnoi et al.
VIRUSES-BASEL (2018)
Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype (vol 9, 873, 2018)
Degao Chen et al.
NATURE COMMUNICATIONS (2018)
Evaluation of the Cytotoxic and Autophagic Effects of Atorvastatin on MCF-7 Breast Cancer Cells
Tugba Alarcon Martinez et al.
BALKAN MEDICAL JOURNAL (2018)
Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
Giulia Marelli et al.
FRONTIERS IN IMMUNOLOGY (2018)
Imidazole Antifungal Drugs Inhibit the Cell Proliferation and Invasion of Human Breast Cancer Cells
Sung Hun Bae et al.
BIOMOLECULES & THERAPEUTICS (2018)
In Vivo Estimation of Oncolytic Virus Populations within Tumors
Mi-Yeon Jung et al.
CANCER RESEARCH (2018)
ENHANCEMENT OF CHEMOTHERAPY USING ONCOLYTIC VIROTHERAPY: MATHEMATICAL AND OPTIMAL CONTROL ANALYSIS
Joseph Malinzi et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2018)
In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs ) on breast cancer cells
Rene Hernandez-Delgadillo et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Oncolytic virus immunotherapy: future prospects for oncology
Junaid Raja et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Study of New Therapeutic Strategies to Combat Breast Cancer Using Drug Combinations
Ana Correia et al.
BIOMOLECULES (2018)
Optimal Control Analysis of a Mathematical Model for Breast Cancer
Segun Isaac Oke et al.
MATHEMATICAL AND COMPUTATIONAL APPLICATIONS (2018)
Immunotherapy for metastatic breast cancer
Tomoharu Sugie
CHINESE CLINICAL ONCOLOGY (2018)
beta 2ARs stimulation in osteoblasts promotes breast cancer cell adhesion to bone marrow endothelial cells in an IL-1 beta and selectin-dependent manner
Lise Clement-Demange et al.
JOURNAL OF BONE ONCOLOGY (2018)
Results of a Doravirine-Atorvastatin Drug-Drug Interaction Study
Sauzanne Khalilieh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer
Alexa Montoya et al.
ONCOTARGET (2017)
Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
Ping-Hsiu Wu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity
Anugraha Rajagopalan et al.
MOLECULAR THERAPY (2017)
The use of nanoparticulates to treat breast cancer
Xiaomeng Tang et al.
NANOMEDICINE (2017)
Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach
Khaphetsi Joseph Mahasa et al.
PLOS ONE (2017)
Repurposing itraconazole as an anticancer agent
Hiroshi Tsubamoto et al.
ONCOLOGY LETTERS (2017)
New Immunotherapy Strategies in Breast Cancer
Lin-Yu Yu et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2017)
Modelling the spatiotemporal dynamics of chemovirotherapy cancer treatment
Joseph Malinzi et al.
JOURNAL OF BIOLOGICAL DYNAMICS (2017)
Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
Eric Wen Su et al.
PEERJ (2017)
Hierarchically Targeted and Penetrated Delivery of Drugs to Tumors by Size-Changeable Graphene Quantum Dot Nanoaircrafts for Photolytic Therapy
Yu-Lin Su et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
Nerve Dependence: From Regeneration to Cancer
Benoni Boilly et al.
CANCER CELL (2017)
Design of efficient computational workflows for in silico drug repurposing
Quentin Vanhaelen et al.
DRUG DISCOVERY TODAY (2017)
Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro
Hui-ping Sun et al.
ACTA PHARMACOLOGICA SINICA (2016)
Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancer
Kui Wang et al.
AUTOPHAGY (2016)
Repositioning of antibiotic levofloxacin as a mitochondrial biogenesis inhibitor to target breast cancer
Min Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
β2-Adrenoceptors on tumor cells play a critical role in stress-enhanced metastasis in a mouse model of breast cancer
Aeson Chang et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
Qianhui Dou et al.
CANCER RESEARCH (2016)
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy
Raphael Serre et al.
CANCER RESEARCH (2016)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
Kinetics of the formation of a protein corona around nanoparticles
Vladimir P. Zhdanov et al.
MATHEMATICAL BIOSCIENCES (2016)
A mixed radiotherapy and chemotherapy model for treatment of cancer with metastasis
A. Ghaffari et al.
MATHEMATICAL METHODS IN THE APPLIED SCIENCES (2016)
Mechanism of hard-nanomaterial clearance by the liver
Kim M. Tsoi et al.
NATURE MATERIALS (2016)
Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells
Giovanna Talarico et al.
SCIENTIFIC REPORTS (2016)
Mathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival Rates
Xiaoqiang Sun et al.
SCIENTIFIC REPORTS (2016)
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts
Chris R. Cardwell et al.
BREAST CANCER RESEARCH (2016)
Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters
Madaswamy S. Muthu et al.
BIOMATERIALS (2015)
Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space
Wen Dai et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2015)
Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells
Rafael Carretero et al.
NATURE IMMUNOLOGY (2015)
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
Zhi-Jie Hou et al.
ONCOTARGET (2015)
RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis
James Finlay et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Novel Theranostic DNA Nanoscaffolds for the Simultaneous Detection and Killing of Escherichia coli and Staphylococcus aureus
Magdiel I. Setyawati et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency
Edward A. Sykes et al.
ACS NANO (2014)
In Vitro Selection of DNA Aptamers for Metastatic Breast Cancer Cell Recognition and Tissue Imaging
Xilan Li et al.
ANALYTICAL CHEMISTRY (2014)
Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer
Wenbing Dai et al.
BIOMATERIALS (2014)
Priorities for the Primary Prevention of Breast Cancer
Graham A. Colditz et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines
Guangxu Jin et al.
DRUG DISCOVERY TODAY (2014)
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
SPECT and Near-Infrared Fluorescence Imaging of Breast Cancer with a Neuropilin-1-Targeting Peptide
Guo-Kai Feng et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Dynamic density functional theory of protein adsorption on polymer-coated nanoparticles
Stefano Angioletti-Uberti et al.
SOFT MATTER (2014)
Drug-target interaction prediction by learning from local information and neighbors
Jian-Ping Mei et al.
BIOINFORMATICS (2013)
Bioreducible PAA-g-PEG graft micelles with high doxorubicin loading for targeted antitumor effect against mouse breast carcinoma
Yong Sun et al.
BIOMATERIALS (2013)
Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers
Rajaletchumy Veloo Kutty et al.
BIOMATERIALS (2013)
Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
P. Liu et al.
BRITISH JOURNAL OF CANCER (2013)
Using Molecular Features of Xenobiotics to Predict Hepatic Gene Expression Response
Guy Haskin Fernald et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Curcumin-derivative nanomicelles for the treatment of triple negative breast cancer
Sebastien Taurin et al.
JOURNAL OF DRUG TARGETING (2013)
The influence of size, shape and vessel geometry on nanoparticle distribution
Jifu Tan et al.
MICROFLUIDICS AND NANOFLUIDICS (2013)
Silver nanoparticles: a novel radiation sensitizer for glioma?
Peidang Liu et al.
NANOSCALE (2013)
Dynamics of Nanoparticle-Protein Corona Complex Formation: Analytical Results from Population Balance Equations
Faryad Darabi Sahneh et al.
PLOS ONE (2013)
Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
Yu-Chi Wang et al.
PLOS ONE (2013)
On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better
Tae-Rin Lee et al.
SCIENTIFIC REPORTS (2013)
Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways
Jing Tang et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
The Role of Magnetic Nanoparticles in the Localization and Treatment of Breast Cancer
M. Ahmed et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Targeting of Primary Breast Cancers and Metastases in a Transgenic Mouse Model Using Rationally Designed Multifunctional SPIONs
Forrest M. Kievit et al.
ACS NANO (2012)
Treatment of breast cancer stem cells with oncolytic herpes simplex virus
J. Li et al.
CANCER GENE THERAPY (2012)
Clotrimazole Preferentially Inhibits Human Breast Cancer Cell Proliferation, Viability and Glycolysis
Cristiane M. Furtado et al.
PLOS ONE (2012)
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
Feixiong Cheng et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Gaussian interaction profile kernels for predicting drug-target interaction
Twan van Laarhoven et al.
BIOINFORMATICS (2011)
Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
N. C. Yip et al.
BRITISH JOURNAL OF CANCER (2011)
Mathematical Modeling Predicts Synergistic Antitumor Effects of Combining a Macrophage-Based, Hypoxia-Targeted Gene Therapy with Chemotherapy
Markus R. Owen et al.
CANCER RESEARCH (2011)
Detectability of Her2 Positive Tumors Using Monoclonal Antibody Conjugated Iron Oxide Nanoparticles in MRI
M. A. Oghabian et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2011)
Cancer immunotherapy - revisited
W. Joost Lesterhuis et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Superparamagnetic iron oxide - Loaded poly (lactic acid)-D-α-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent
Chandrasekharan Prashant et al.
BIOMATERIALS (2010)
Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment
Pei Wang et al.
CANCER LETTERS (2010)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16
Gijs W. D. Landman et al.
DIABETES CARE (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target
Erik D. Wiklund et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Histological types of breast cancer: How special are they?
Britta Weigelt et al.
MOLECULAR ONCOLOGY (2010)
Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid
Daniele Dell'Orco et al.
PLOS ONE (2010)
Solving the apparent diversity-accuracy dilemma of recommender systems
Tao Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice
Tapan K. Jain et al.
BIOMATERIALS (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
Michael M. Schmidt et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Michael Gnant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prediction of drug-target interaction networks from the integration of chemical and genomic spaces
Yoshihiro Yamanishi et al.
BIOINFORMATICS (2008)
Immunotherapy with interleukin-2: A study based on mathematical modeling
Sandip Banerjee
INTERNATIONAL JOURNAL OF APPLIED MATHEMATICS AND COMPUTER SCIENCE (2008)
Oncolytic viruses in cancer therapy
Markus J. V. Vaha-Koskela et al.
CANCER LETTERS (2007)
Mathematical models of targeted cancer therapy
L. H. Abbott et al.
BRITISH JOURNAL OF CANCER (2006)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Analytical model of magnetic nanoparticle transport and capture in the microvasculature
E. P. Furlani et al.
PHYSICAL REVIEW E (2006)
Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases
Nidhi et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
The effective dispersion of nanovectors within the tumor microvasculature
P Decuzzi et al.
ANNALS OF BIOMEDICAL ENGINEERING (2006)
Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells
N Kohler et al.
LANGMUIR (2005)
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
VN Anisimov et al.
EXPERIMENTAL GERONTOLOGY (2005)
A theoretical model for the margination of particles within blood vessels
P Decuzzi et al.
ANNALS OF BIOMEDICAL ENGINEERING (2005)
The dynamics of an optimally controlled tumor model: A case study
LG De Pillis et al.
MATHEMATICAL AND COMPUTER MODELLING (2003)
Optimal scheduling of radiotherapy and angiogenic inhibitors
A Ergun et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2003)
MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles
D Artemov et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Sequencing surgery, radiotherapy and chemotherapy: insights from a mathematical analysis
DR Beil et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Share Paper
